IPO roundup: IMAX China and Dr Lal in the limelight
Stefan Rajewski - Fotolia
IMAX China started testing investor appetite for its $300m-$500m IPO in Hong Kong on Tuesday, even as sentiment in equity markets remained dour and shares in the city fell 0.49%, tracking losses in Shanghai.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts